首页> 美国卫生研究院文献>Aging (Albany NY) >Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma
【2h】

Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma

机译:弥散性胶质瘤临床预后相关的能量代谢相关特征的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Now, numerous exciting findings have been yielded in the field of energy metabolism within glioma cells. In addition to aerobic glycolysis, multiple catabolic pathways are employed for energy production. However, the prognostic significance of energy metabolism in glioma remains obscure. Here, we explored the relationship between energy metabolism gene profile and outcome of diffuse glioma patients using The Cancer Genome Altas (TCGA) and Chinese Glioma Genome Altas (CGGA) datasets. Based on the gene expression profile, consensus clustering identified two robust clusters of glioma patients with distinguished prognostic and molecular features. With the Cox proportional hazards model with elastic net penalty, an energy metabolism-related signature was built to evaluate patients’ prognosis. Kaplan-Meier analysis found that the acquired signature could differentiate the outcome of low and high-risk groups of patients in both cohorts. Moreover, the signature, significantly associated with the clinical and molecular features, could serve as an independent prognostic factor for glioma patients. Gene Ontology (GO) and Gene Set Enrichment Analysis (GSEA) showed that gene sets correlated with high-risk group were involved in immune and inflammatory response, with the low-risk group were mainly related to glutamate receptor signaling pathway. Our results provided new insight into energy metabolism role in diffuse glioma.
机译:现在,在神经胶质瘤细胞内的能量代谢领域已经产生了许多令人兴奋的发现。除有氧糖酵解外,多种分解代谢途径均用于产生能量。然而,胶质瘤中能量代谢的预后意义仍然不清楚。在这里,我们使用癌症基因组阿尔塔斯(TCGA)和中国胶质瘤基因组阿尔塔斯(CGGA)数据集探索了能量代谢基因谱与弥漫性胶质瘤患者预后之间的关系。基于基因表达谱,共识聚类确定了两个具有明显预后和分子特征的神经胶质瘤患者的稳健簇。利用具有弹性净罚分的Cox比例风险模型,建立了能量代谢相关的特征来评估患者的预后。 Kaplan-Meier分析发现,获得的特征可以区分两组的低风险和高风险患者的结果。而且,与临床和分子特征显着相关的特征可以作为神经胶质瘤患者的独立预后因素。基因本体论(GO)和基因组富集分析(GSEA)表明,与高危人群相关的基因组参与了免疫和炎症反应,而低危人群主要与谷氨酸受体信号通路相关。我们的结果为弥散性胶质瘤中能量代谢的作用提供了新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号